Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-roscovitine in Pituitary Cushing Disease
NCT02160730Phase 2Terminated
- Start
- May 2014
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of seliciclib in Cushing's disease (CD). Started May 2014; status: terminated.
02
Drugs
seliciclib
03
Conditions
Cushing's disease (CD)
Beyond the preview
Go deeper on NCT02160730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02160730.